申请人:Veltri P. Enrico
公开号:US20060069080A1
公开(公告)日:2006-03-30
The present invention provides compositions, therapeutic combinations and methods including: (a) at least one selective CB
1
antagonist; and (b) at least one substituted azetidinone or substituted β-lactam sterol absorption inhibitor which can be useful for treating vascular conditions, diabetes, obesity, metabolic syndrome and lowering plasma levels of sterols or 5α-stanols.
本发明提供了包括以下内容的组合物、治疗组合和方法:(a)至少一种选择性CB1拮抗剂;和(b)至少一种取代的氮杂环丁烷或取代的β-内酰胺甾醇吸收抑制剂,可用于治疗血管疾病、糖尿病、肥胖、代谢综合征以及降低血浆中的甾醇或5α-甾烷醇水平。